ArticleCancer gene therapy2007

Tumor-specific dendritic cells generated by genetic redirection of Toll-like receptor signaling against the tumor-associated antigen, erbB2.

Y Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.